Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study
Yan Yan, Chantsalmaa Davgadorj, Chunyan Lyu, Shiliang Zhang, Yuanwang Qiu
Topics & Concepts
ImmunogenicityMedicineVirologyTuberculosisCoronavirus disease 2019 (COVID-19)Cross-sectional studyHuman immunodeficiency virus (HIV)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyAntibodyInternal medicineDiseasePathologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsVaccine Coverage and Hesitancy